Drug Testing Locations in Illinois

Accredited Drug Testing has 579 drug testing centers in 1,558 IL cities.

Please select a city from the list below to find drug test centers in Illinois.

Why Illinois Employers Choose Our Drug Testing Services

Illinois employers rely on our drug testing services to ensure a safe and productive work environment. With 579 test centers across 1,560 cities, we offer unmatched accessibility and convenience, making it easy for employers to maintain compliance with state and federal regulations.

Our commitment to accuracy and confidentiality reassures employers that they're selecting a trusted partner in maintaining workplace integrity. The wide reach of our services across Illinois enables consistent and efficient testing processes, crucial for any business.

By using our services, employers can minimize the risks associated with drug-related workplace incidents. Our comprehensive testing helps in identifying substances that could impair performance, thus protecting both staff and company assets.

Further, our services provide timely results and detailed reporting, assisting employers in making informed decisions quickly. This level of efficiency proves invaluable in the fast-paced business environment.

Join the growing number of Illinois businesses prioritizing safety and efficiency. Our expansive network ensures you're always supported effectively, wherever your business operates across Illinois.

Illinois Drug Free Workplace Programs

Illinois has taken proactive steps to promote a drug-free work environment. Through various initiatives, the state aims to create a safer and more productive workplace for all employees. One such effort is the emphasis on education and prevention programs that target substance abuse, ensuring that workers have access to the resources they need to make informed decisions. By fostering a culture of awareness and support, Illinois strives to mitigate the risks associated with drug use in professional settings.

Additionally, Illinois encourages employers to implement comprehensive drug policies that align with state guidelines. These policies often include mandatory drug testing, access to counseling services, and employee assistance programs. Such measures not only protect business interests but also promote the well-being of employees by providing them with the necessary tools to maintain a healthy, drug-free lifestyle. Employers are encouraged to collaborate with state resources to enhance their efforts in sustaining a drug-free workplace.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Mobile/On-Site Drug Testing

If you're an employer needing to test 25 or more employees and looking to save time and money, we offer mobile on-site drug testing where we come to you. Call us today for more information.

Illinois Laws on Drugs

Illinois drug laws classify controlled substances into schedules based on their potential for abuse and accepted medical use. Cocaine, heroin, and LSD are Schedule I, meaning high potential for abuse and no accepted medical use. Penalties for possession are severe, with potential imprisonment and hefty fines.

Prescription drug offenses are also heavily regulated. Illinois has implemented prescription monitoring programs to prevent illegal distribution and misuse. Violations can result in criminal charges, emphasizing the state's strong stance on controlling drug abuse.

Illinois Laws on Marijuana

Since legalizing recreational marijuana, Illinois permits adults 21 and over to possess up to 30 grams of flower and 500 milligrams of THC in products. Medical marijuana patients can cultivate up to five plants. Consumption is restricted to private residences and certain approved venues.

Illinois law prohibits marijuana use in public, vehicles, and near schools. While possession for personal use is legalized, selling cannabis without a license remains illegal. Employers may enforce drug-free workplace policies, though rights for medical users are protected under specific conditions.

Illinois Drug Resources

Illinois Department of Public Health
Resource for public health guidance and drug prevention.

Illinois Department of Human Services
Support for substance abuse and community resources.

Recovery.org
Find recovery centers and treatment options in Illinois.

SAMHSA
National helpline and treatment resource guidance.

Chestnut Health Systems
Comprehensive behavioral health services and support.

ReachOut Illinois
Supportive counseling and drug counseling services.

Gateway Foundation
Treatment programs addressing substance abuse disorders.

University of Illinois at Chicago
Research and community programs on substance abuse.

Hazelden Betty Ford Foundation
Leading treatment center network with Illinois locations.

Partnership to End Addiction
Resources for employers and parents on fighting addiction.

Illinois Criminal Justice Information Authority
State agency providing resources on criminal justice issues.

Drug Testing Near , IL

Frequently Asked Questions

Customer Reviews